🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07464288
Starting soon Not applicable

Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries

NCT07464288 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-03-23
Last updated
2026-03-17

Condition(s) studied

Driving PressureNeuromuscular Blockade MonitoringPostoperative Respiratory Complications

Investigational drug(s) / intervention(s)

Rocuronium →

Rocuronium: Rocuronium will be administered intravenously as bolus and continuous infusion to achieve target neuromuscular blockade depth according to group allocation. Neuromuscular function will be monitored using quantitative TOF monitoring.

Study summary

This randomized controlled study aims to evaluate the effects of deep versus moderate neuromuscular blockade on intraoperative driving pressure and the development of postoperative critical respiratory events in patients undergoing abdominal surgery under general anesthesia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Elective abdominal surgery under general anesthesia that is expected to last longer than one hour * ASA I-II-III * Age ≥18 years * Written informed consent Exclusion Criteria: * Refusal to participate in the study * ASA ≥ IV * Age \<18 * Obesity (BMI\>30) and cachexia (BMI \<18) * Laparoscopic surgery * Emergency procedure * Allergy to drugs used during induction and maintenance of general anesthesia * Presence of psychiatric/neurologic/neuromuscular disease * Risk of malignant hyperthermia or having any relative with history of malignant hyperthermia * Use of medications that may affect neuromuscular function (anticonvulsants, aminoglycosides, magnesium salts, etc.) * Pregnancy * Presence of advanced chronic lung disease (asthma, COPD, etc.) * Presence of advanced liver and renal disease (creatinine\>1.6, liver function tests above twice the normal range)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Bilkent City Hospital Ankara Çankaya

More Ankara City Hospital Bilkent trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07464288 on ClinicalTrials.gov ↗ ← All trials in Turkey